Covid vaccine boosters approved for vulnerable groups in Switzerland
People with a high risk of developing serious complications from Covid-19 may now receive a third vaccine booster jab, the Swiss medicines regulator has stated.
This content was published on
3 minutes
swissinfo.ch/mga
Español
es
Suiza avala la dosis de refuerzo de la vacuna contra la COVID-19
Swissmedic cleared the use of boosters from vaccine makers Moderna (Spikevax) and Pfizer/Biontech (Comirnaty).
“People at especially high risk can receive a booster dose of a vaccine in order to remain adequately protected against severe episodes of Covid-19,” Swissmedic stated on TuesdayExternal link.
This includes immunocompromised people or patients with a weak or non-existent immune response from previous jabs. This could include people who have undergone an organ transplant or cancer patients.
“The latest study data indicate that an additional dose can increase the ability to form antibodies against the coronavirus SARS-CoV-2, particularly in patients with a weakened immune system,” said Swissmedic. “Those who are at especially high risk can also benefit from a booster dose.”
The Federal Office of Public Health said the booster jab should be limited to vulnerable sections of the population, including people aged over 65.
“For the general population, a booster vaccination is currently not permitted and not recommended due to the current data situation,” health officials stated on TuesdayExternal link.
People can start applying for a third booster jab from the beginning of next month when IT systems will be ready to deal with the expected flow of requests.
Dose schedule
A third dose for vulnerable people can now be administered at least six months after they received their second dose. For patients who showed little or no immune response reaction to their first two jabs, a booster can be administered after 28 days of the second jab.
The booster jab will be administered at the usual dosage for the Comirnaty vaccine and a half dose for the Spikevax vaccine.
Switzerland received some 7,700 extra vaccine doses at the end of last week. The government has ordered seven million new doses from Moderna and Pfizer/BioNtech to be delivered next year.
The number of new infections has been rising in Switzerland in recent weeks. Some 1,491 cases were reported on Tuesday, mainly among younger people. The seven-day average stands at 1,237 – an increase of 35% from the previous period.
However, the number of hospitalisations remains stable and there has been a slight decrease in the number of deaths.
During a press conference on Tuesday, Tanja Stadler, head of Switzerland’s Covid-19 science taskforce, said that two vaccine jabs can prevent eight out of ten hospitalisations.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Swiss money laundering office registers record number of reports
This content was published on
The Money Laundering Reporting Office Switzerland (MROS) registered a record number of reports of suspicious activity last year.
Two teens accused of planning terror attack released from custody
This content was published on
The Schaffhausen judiciary has released the two teenagers from custody who allegedly planned bomb attacks in Switzerland.
OECD: Sluggish economic activity slowing growth in Switzerland
This content was published on
Sluggish economic activity at the start of the year is weighing on growth in Switzerland, with GDP expected to fall to 1.1% in 2024.
Report finds mistakes which led to Swiss government data breach
This content was published on
Mistakes were made by both the government and internet company Xplain in the case of a criminal cyber-attack on the Bern-based IT business.
Swiss government wants better gender balance in federal administration
This content was published on
New Swiss government personnel management targets say there must be even more female managers in the federal administration.
Swiss national science foundation funded over 5,000 projects in 2023
This content was published on
In 2023, the Swiss National Science Foundation (SNSF) provided a total of CHF961 million worth of funding towards research projects.
Switzerland invites 160 delegations to June Ukraine peace talks
This content was published on
Russia is currently not among the delegations invited to talks aimed at helping bring about peace in the conflict between Moscow and Ukraine.
Survey: air travel most popular way to go on holidays for Swiss
This content was published on
Despite the climate crisis, flying is the most popular mode of transport for private travel – particularly among young, urban and high-income travellers.
Swiss government to use phone data to identify asylum seekers
This content was published on
From April 2025, authorities plan to be able to analyse data from mobile phones, computers and other data carriers to identify asylum seekers.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland awaits regulator’s verdict on Covid booster shots
This content was published on
On Thursday, Swiss Health Minister Alain Berset said the government and cantons are awaiting Swissmedic’s recommendation of a third dose of the vaccine before proceeding. “We have regular exchanges with the Federal Vaccination Commission and the cantons. We are waiting for the decision of Swissmedic,” Berset said. That could be a matter of days or weeks, according…
Over 1% of recent Swiss Covid-19 fatalities were fully vaccinated
This content was published on
Of the 1,100 people killed by the coronavirus in Switzerland since the end of January, 18 had received both doses of the vaccine.
Swiss expect approval of Covid-19 booster by end of October
This content was published on
Switzerland’s medical regulator has said that it expects to give the greenlight for the third Covid-19 jab in a matter of weeks.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.